• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I CMV IGG REAGENT KIT; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I CMV IGG REAGENT KIT; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS Back to Search Results
Catalog Number 07P42-32
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/07/2024
Event Type  malfunction  
Event Description
The customer observed false nonreactive alinity i cmv igg results for one patient.The sample was repeated three more times and a reactive result was obtained.The following data was provided: sid (b)(6): first run (1:10 dilution) = <11 au/ml, second run (undiluted) = >250 au/ml, third run (1:10 dilution) = <11 au/ml, fourth run (1:10 dilution) = 600 au/ml.Per the alinity i cmv igg package insert, interpretation of results section: specimens with concentration values = 6.0 au/ml are considered reactive and < 6.0 au/ml are considered nonreactive.There was no impact to patient management reported.
 
Manufacturer Narrative
This report is being filed on an international product, alinity i cmv igg, list number 07p42-32, that has a similar product distributed in the us, list number 7p42-24/-33.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
The complaint investigation for false nonreactive alinity i cmv igg results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, device history record review, and labeling review.Additionally, in-house testing of retained reagent kit was also completed.Return testing was not completed as returns were not available.The data and information provided by the customer were reviewed and support the complaint issue.A ticket search by lot indicates that the reagent lot performs as expected for this product.A review of the complaint trending report did not identify any trends for the issue for the product.A review of the device history record did not identify any non-conformances or deviations with the lot number 51601fn00 and the complaint issue.A review of labeling was performed and found to sufficiently address the customer's issue.Furthermore, clinical sensitivity testing was performed using an in-house retained reagent kit of the complaint lot.All specifications were met which indicates the lot is performing as expected.Based on our investigation, no systemic issue or deficiency with the alinity i cmv igg reagent for lot 51601fn00 was identified.
 
Event Description
The customer observed false nonreactive alinity i cmv igg results for one patient.The sample was repeated three more times and a reactive result was obtained.The following data was provided: sid (b)(6): first run (1:10 dilution) = <11 au/ml second run (undiluted) = >250 au/ml third run (1:10 dilution) = <11 au/ml fourth run (1:10 dilution) = 600 au/ml per the alinity i cmv igg package insert, interpretation of results section: specimens with concentration values = 6.0 au/ml are considered reactive and < 6.0 au/ml are considered nonreactive.There was no impact to patient management reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I CMV IGG REAGENT KIT
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key18603485
MDR Text Key334495598
Report Number3008344661-2024-00013
Device Sequence Number1
Product Code LFZ
Combination Product (y/n)N
Reporter Country CodeKZ
PMA/PMN Number
K220949
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/29/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07P42-32
Device Lot Number51601FN00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/28/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/16/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, (B)(6); ALNTY I PROCESSING MODU, 03R65-01, (B)(6)
-
-